+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Nonopioid Management of Neonatal Abstinence Syndrome



Nonopioid Management of Neonatal Abstinence Syndrome



Advances in Neonatal Care 17(2): 84-90



Current standard therapy for moderate to severe neonatal abstinence syndrome (NAS) includes opioid administration and often results in separation of mother and infant. Impaired maternal-infant bonding and extended neonatal opiate exposure may be associated with adverse developmental outcomes. Increased use of nonopioid adjunctive NAS therapies may decrease postnatal opioid exposure and length of stay (LOS), thereby promoting positive developmental outcomes for NAS-affected infants. To review the efficacy of rooming-in care and acupuncture as nonpharmacologic adjunctive agents to reduce the magnitude of postnatal opioid exposure and LOS. PubMed, Ovid Medline, Embase, and CINAHL databases were searched for primary studies on rooming-in care and acupuncture as adjunctive treatments for NAS; 8 are included in this review. Rooming-in care may decrease postnatal opioid exposure and LOS in NAS-affected infants. Acupuncture is safe in NAS patients; however, its definitive effect on narcotic use and length of hospitalization are inconclusive. Rooming-in care should be offered to NAS patients. Strong evidence does not exist to recommend acupuncture as a routine NAS treatment. Additional randomized clinical trials are necessary to assess the efficacy of acupuncture and to confirm the effect of rooming-in care on NAS outcomes, and delineate optimal elements of a rooming-in care model.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 060024946

Download citation: RISBibTeXText

PMID: 28002062

DOI: 10.1097/anc.0000000000000371


Related references

Neonatal abstinence syndrome--postnatal ward versus neonatal unit management. European Journal of Pediatrics 169(1): 95-98, 2010

Neonatal abstinence syndrome: assessment and management. Addictive Diseases 2(1-2): 141-158, 1975

Pharmacologic management of neonatal abstinence syndrome. Journal of Perinatal and Neonatal Nursing 9(4): 70-80, 1996

Identification and management of neonatal abstinence syndrome. Journal of Infusion Nursing 28(3): 159-167, 2005

Management of neonatal abstinence syndrome from opioids. Clinics in Perinatology 40(3): 509-524, 2013

Breastfeeding promotion for management of neonatal abstinence syndrome. Journal of Obstetric Gynecologic and Neonatal Nursing 42(5): 517-526, 2014

Pediatric management problems. Neonatal abstinence syndrome. Pediatric Nursing 15(5): 505, 1989

Review of the assessment and management of neonatal abstinence syndrome. Addiction Science & Clinical Practice 9(1): 19-19, 2015

Use of clonidine in the prevention and management of neonatal abstinence syndrome. Clinical Toxicology 47(6): 551-555, 2009

Nursing management of neonatal opiate abstinence syndrome. Hu Li Za Zhi Journal of Nursing 55(6): 68-72, 2008

Pharmacological Management of Neonatal Opioid Abstinence Syndrome. Cns Drugs 8(6): 448-456, 1997

What is the best evidence based management of neonatal abstinence syndrome?. Archives of Disease in Childhood. Fetal and Neonatal Edition 91(6): F463, 2006

Management of neonatal abstinence syndrome in the newborn nursery. Nursing for Women's Health 18(6): 509-514, 2014

Pharmacologic management of the opioid neonatal abstinence syndrome. Pediatric Clinics of North America 59(5): 1147-1165, 2012

The complex factors determining neonatal abstinence syndrome and its management. European Addiction Research 18(6): 322; Author Reply 323, 2012